Methylenedioxymethoxyethylamphetamine
| Clinical data | |
|---|---|
| Other names | 3,4-Methylenedioxy-N-methoxyethylamphetamine; MDMEOET; MDMEOETA; N-Methoxyethyl-MDA |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H19NO3 |
| Molar mass | 237.299 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
MDMEOET, also known as 3,4-methylenedioxy-N-methoxyethylamphetamine or as N-methoxyethyl-MDA, is a psychoactive drug of the phenethylamine, amphetamine, and MDxx families.[1] It is the N-methoxyethyl derivative of MDA.[1]
Use and effects
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDMEOET's dose as greater than 180 mg orally and its duration as unknown.[1] It prdouced few or no effects at tested doses.[1]
Chemistry
Synthesis
The chemical synthesis of MDMEOET has been described.[1]
Society and culture
Legal status
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]
See also
References
- ^ a b c d e f g Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
- ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.